InvestorsObserver
×
News Home

What is Wall Street's Target Price for Evoke Pharma Inc (EVOK) Stock?

Thursday, January 14, 2021 02:09 PM | InvestorsObserver Analysts

Mentioned in this article

What is Wall Street's Target Price for Evoke Pharma Inc (EVOK) Stock?

InvestorsObserver is giving Evoke Pharma Inc (EVOK) an Analyst Rating Rank of 79, meaning EVOK is ranked higher by analysts than 79% of stocks. The average projection by analysts for EVOK is $10 over the next 12 months and analyst’s classify the stock as a Strong Buy

Overall Score - 5
Wall Street analysts are rating EVOK a Strong Buy today. Find out what this means to you and get the rest of the rankings on EVOK!

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.

InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Evoke Pharma Inc Stock Today?

Evoke Pharma Inc (EVOK) stock is trading at $2.85 as of 2:08 PM on Thursday, Jan 14, an increase of $0.12, or 4.21% from the previous closing price of $2.73. Volume today is above average. So far 1,805,641 shares have traded compared to average volume of 325,737 shares. The stock has traded between $2.60 and $3.05 so far today.

Click Here to get the full report on Evoke Pharma Inc (EVOK) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App